Mucosis' Series B Round

Mucosis raised a round of funding on April 15, 2014.

Mucosis is a clinical-stage Dutch biotechnology company with a proprietary platform technology, Mimopath, on which it develops novel vaccines using various routes of administration including those tha…

Articles about Mucosis' Series B Round: